Lactobacillus and Emgality drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lactobacillus (lactobacillus) and Emgality (galcanezumab-gnlm). Common drug interactions include urinary tract infection among females and multiple fractures among males.

The phase IV clinical study analyzes what interactions people have when they take Lactobacillus and Emgality. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Lactobacillus?

Lactobacillus has active ingredients of lactobacillus. It is often used in stomach discomfort. eHealthMe is studying from 5,854 Lactobacillus users. Check the latest studies of Lactobacillus.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.



On Jul, 14, 2026

11 people who take Lactobacillus and Emgality together, and have interactions are studied.

Lactobacillus and Emgality drug interactions.

What are the common drug interactions of Lactobacillus and Emgality, by gender? *:

female:

  1. Urinary tract infection
  2. Viral infection
  3. Vulval cellulitis (inflammation of skin around vagina)
  4. Wheezing (a high-pitched whistling sound made while you breath)
  5. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  6. Memory impairment
  7. Arthralgia (joint pain)
  8. Bone cyst
  9. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  10. Chills (felling of cold)

male:

  1. Multiple fractures
  2. Nasal septum deviation (deviated nasal septum)

What are the common drug interactions of Lactobacillus and Emgality, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Blood iron decreased
  2. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  3. Fall
  4. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  5. Headache (pain in head)
  6. Urinary tract infection
  7. Viral infection
  8. Vulval cellulitis (inflammation of skin around vagina)
  9. Wheezing (a high-pitched whistling sound made while you breath)
  10. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)

40-49:

  1. Adverse drug reaction
  2. Apathy
  3. Arthralgia (joint pain)
  4. Depression
  5. Fatigue (feeling of tiredness)
  6. Suicidal ideation

50-59:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Cellulitis (infection under the skin)
  3. Nausea (feeling of having an urge to vomit)
  4. Pain
  5. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  6. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  7. Pyrexia (fever)
  8. Ulcer haemorrhage (bleeding ulcer)
  9. Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
  10. Fatigue (feeling of tiredness)

60+:

n/a

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 36.36%
  2. Immunodeficiency Common Variable: 3 people, 27.27%
  3. Headache (pain in head): 2 people, 18.18%
  4. Primary Immunodeficiency Syndrome: 1 person, 9.09%
  5. Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 1 person, 9.09%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 9.09%
  7. Migraine (headache): 1 person, 9.09%
  8. Dyskinesia (abnormality or impairment of voluntary movement): 1 person, 9.09%
  9. Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lactobacillus and Emgality?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lactobacillus and Emgality:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lactobacillus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Emgality:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lactobacillus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emgality and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lactobacillus and galcanezumab-gnlm (the active ingredients of Lactobacillus and Emgality, respectively), and Lactobacillus and Emgality (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: